ArticleRadiology2018

Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand-1 Expression for Immunotherapy in Non-Small Cell Lung Cancer.

Emily B Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.